Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)?

CA Tierney; H Chinoy; C Chattopadhyay

Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)?

CA Tierney, H Chinoy, C Chattopadhyay

Research output: Contribution to conference › Poster

Original language	English
Pages	II76-II76
Publication status	Published - Apr 2008
Event	Annual Meeting of the British-Society-Rheumatology - Liverpool, United Kingdom Duration: 22 Apr 2008 → 25 Apr 2008

Conference

Conference	Annual Meeting of the British-Society-Rheumatology
Country/Territory	United Kingdom
City	Liverpool
Period	22/04/08 → 25/04/08

Cite this

Tierney, CA., Chinoy, H., & Chattopadhyay, C. (2008). Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)?. II76-II76. Poster session presented at Annual Meeting of the British-Society-Rheumatology, Liverpool, United Kingdom.

Tierney, CA ; Chinoy, H ; Chattopadhyay, C. / Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)?. Poster session presented at Annual Meeting of the British-Society-Rheumatology, Liverpool, United Kingdom.

@conference{77c32b068d124201b4d97a49c6b3cb1b,

title = "Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)?",

author = "CA Tierney and H Chinoy and C Chattopadhyay",

note = "IDS Number: 284BT ISSN: 1462-0324; Annual Meeting of the British-Society-Rheumatology ; Conference date: 22-04-2008 Through 25-04-2008",

year = "2008",

month = apr,

language = "English",

pages = "II76--II76",

}

Tierney, CA, Chinoy, H & Chattopadhyay, C 2008, 'Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)?', Annual Meeting of the British-Society-Rheumatology, Liverpool, United Kingdom, 22/04/08 - 25/04/08 pp. II76-II76.

Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)? / Tierney, CA; Chinoy, H; Chattopadhyay, C.

2008. II76-II76 Poster session presented at Annual Meeting of the British-Society-Rheumatology, Liverpool, United Kingdom.

Research output: Contribution to conference › Poster

TY - CONF

T1 - Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)?

AU - Tierney, CA

AU - Chinoy, H

AU - Chattopadhyay, C

N1 - IDS Number: 284BT ISSN: 1462-0324

PY - 2008/4

Y1 - 2008/4

M3 - Poster

SP - II76-II76

T2 - Annual Meeting of the British-Society-Rheumatology

Y2 - 22 April 2008 through 25 April 2008

ER -

Tierney CA, Chinoy H, Chattopadhyay C. Is it necessary to perform sequential bath ankylosing spondylitis disease activity index (BASDAI) and spinal visual analogue scale (VAS) measurements prior to commencement of anti-tumour necrosis factor (TNF) alpha therapy in ankylosing spondylitis (AS)?. 2008. Poster session presented at Annual Meeting of the British-Society-Rheumatology, Liverpool, United Kingdom.